Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer in Colorectal Cancer Patients
Table 4
Follow-up endoscopic findings in colorectal cancer group and control group.
Endoscopic findings
Colorectal cancer patients ()
Control group ()
value
Chronic atrophic gastritis
86 (66.7%)
289 (69.3%)
0.572
Intestinal metaplasia
32 (24.8%)
56 (13.4%)
0.002
Gastric ulcer
7 (5.4%)
11 (2.6%)
0.121
Duodenal ulcer
7 (5.4%)
11 (2.6%)
0.121
Hyperplastic polyp
5 (3.9%)
35 (8.4%)
0.085
Gastric adenoma
9 (7.0%)
9 (2.2%)
0.007
Gastric cancer
13 (10.0%)
2 (0.5%)
<0.001
Subepithelial tumor (SET)
3 (2.3%)
0 (0%)
0.002
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
